JBIO
Nuveen Asset Management’s Jade Biosciences, Inc. Common Stock JBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $106K | Hold |
40,047
| – | – | ﹤0.01% | 3284 |
|
|
2024
Q3 | $83.7K | Hold |
40,047
| – | – | ﹤0.01% | 3317 |
|
|
2024
Q2 | $66.5K | Hold |
40,047
| – | – | ﹤0.01% | 3317 |
|
|
2024
Q1 | $1.18M | Hold |
40,047
| – | – | ﹤0.01% | 2629 |
|
|
2023
Q4 | $906K | Buy |
40,047
+3,737
| +10% | +$84.6K | ﹤0.01% | 2779 |
|
|
2023
Q3 | $493K | Hold |
36,310
| – | – | ﹤0.01% | 2850 |
|
|
2023
Q2 | $623K | Hold |
36,310
| – | – | ﹤0.01% | 2849 |
|
|
2023
Q1 | $732K | Sell |
36,310
-802
| -2% | -$16.2K | ﹤0.01% | 2709 |
|
|
2022
Q4 | $1.09M | Buy |
37,112
+2,136
| +6% | +$62.6K | ﹤0.01% | 2650 |
|
|
2022
Q3 | $580K | Sell |
34,976
-3,812
| -10% | -$63.2K | ﹤0.01% | 2929 |
|
|
2022
Q2 | $606K | Buy |
38,788
+24,470
| +171% | +$382K | ﹤0.01% | 2965 |
|
|
2022
Q1 | $209K | Hold |
14,318
| – | – | ﹤0.01% | 3185 |
|
|
2021
Q4 | $157K | Hold |
14,318
| – | – | ﹤0.01% | 3259 |
|
|
2021
Q3 | $300K | Buy |
+14,318
| New | +$300K | ﹤0.01% | 3253 |
|